A detailed history of Assetmark, Inc transactions in Genmab A/S stock. As of the latest transaction made, Assetmark, Inc holds 82,629 shares of GMAB stock, worth $1.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
82,629
Previous 71,110 16.2%
Holding current value
$1.69 Million
Previous $1.79 Million 12.77%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$23.84 - $28.48 $274,612 - $328,061
11,519 Added 16.2%
82,629 $2.01 Million
Q2 2024

Aug 13, 2024

BUY
$25.13 - $30.27 $147,890 - $178,138
5,885 Added 9.02%
71,110 $1.79 Million
Q1 2024

May 06, 2024

BUY
$26.43 - $32.77 $573,716 - $711,338
21,707 Added 49.88%
65,225 $1.95 Million
Q4 2023

Feb 09, 2024

BUY
$27.94 - $35.44 $73,649 - $93,419
2,636 Added 6.45%
43,518 $1.39 Million
Q3 2023

Oct 27, 2023

BUY
$35.27 - $42.24 $141,820 - $169,847
4,021 Added 10.91%
40,882 $1.44 Million
Q2 2023

Aug 11, 2023

BUY
$37.4 - $42.94 $282,594 - $324,454
7,556 Added 25.78%
36,861 $1.4 Million
Q1 2023

May 05, 2023

BUY
$34.88 - $43.22 $150,611 - $186,623
4,318 Added 17.28%
29,305 $1.11 Million
Q4 2022

Feb 10, 2023

SELL
$33.8 - $47.06 $12,539 - $17,459
-371 Reduced 1.46%
24,987 $1.06 Million
Q3 2022

Nov 01, 2022

BUY
$31.52 - $373.61 $188,899 - $2.24 Million
5,993 Added 30.95%
25,358 $815,000
Q2 2022

Aug 03, 2022

BUY
$26.83 - $38.57 $179,519 - $258,071
6,691 Added 52.79%
19,365 $629,000
Q1 2022

May 13, 2022

BUY
$30.95 - $39.68 $129,773 - $166,378
4,193 Added 49.44%
12,674 $459,000
Q4 2021

Feb 14, 2022

SELL
$35.87 - $47.12 $1.42 Million - $1.86 Million
-39,573 Reduced 82.35%
8,481 $336,000
Q3 2021

Nov 12, 2021

BUY
$41.55 - $48.72 $176,753 - $207,254
4,254 Added 9.71%
48,054 $2.1 Million
Q2 2021

Aug 16, 2021

BUY
$32.88 - $44.57 $477,614 - $647,423
14,526 Added 49.62%
43,800 $1.79 Million
Q1 2021

May 14, 2021

BUY
$30.92 - $44.4 $75,011 - $107,714
2,426 Added 9.04%
29,274 $961,000
Q4 2020

Feb 10, 2021

BUY
$33.66 - $40.76 $282,239 - $341,772
8,385 Added 45.42%
26,848 $1.09 Million
Q3 2020

Nov 13, 2020

BUY
$33.07 - $38.68 $506,037 - $591,881
15,302 Added 484.09%
18,463 $676,000
Q2 2020

Aug 11, 2020

SELL
$20.05 - $33.89 $17,263 - $29,179
-861 Reduced 21.41%
3,161 $107,000
Q1 2020

May 12, 2020

SELL
$17.15 - $25.22 $21,934 - $32,256
-1,279 Reduced 24.13%
4,022 $85,000
Q4 2019

Feb 11, 2020

BUY
$18.88 - $24.14 $22,278 - $28,485
1,180 Added 28.63%
5,301 $118,000
Q3 2019

Nov 13, 2019

BUY
$18.0 - $21.38 $74,178 - $88,106
4,121 New
4,121 $83,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.5B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.